Product Details for NDA 050625
SANDIMMUNE (CYCLOSPORINE)
25MG
Marketing Status: Prescription
50MG
Marketing Status: Prescription
100MG
Marketing Status: Prescription
25MG
Marketing Status: Prescription
Active Ingredient: CYCLOSPORINE
Proprietary Name: SANDIMMUNE
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 25MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB2
Application Number: N050625
Product Number: 001
Approval Date: Mar 2, 1990
Applicant Holder Full Name: NOVARTIS PHARMACEUTICALS CORP
Marketing Status: Prescription
Patent and Exclusivity Information
SANDIMMUNE (CYCLOSPORINE)
Proprietary Name: SANDIMMUNE
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 25MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB2
Application Number: N050625
Product Number: 001
Approval Date: Mar 2, 1990
Applicant Holder Full Name: NOVARTIS PHARMACEUTICALS CORP
Marketing Status: Prescription
Patent and Exclusivity Information
50MG
Marketing Status: Prescription
Active Ingredient: CYCLOSPORINE
Proprietary Name: SANDIMMUNE
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 50MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: BX
Application Number: N050625
Product Number: 003
Approval Date: Nov 23, 1992
Applicant Holder Full Name: NOVARTIS PHARMACEUTICALS CORP
Marketing Status: Prescription
Patent and Exclusivity Information
SANDIMMUNE (CYCLOSPORINE)
Proprietary Name: SANDIMMUNE
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 50MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: BX
Application Number: N050625
Product Number: 003
Approval Date: Nov 23, 1992
Applicant Holder Full Name: NOVARTIS PHARMACEUTICALS CORP
Marketing Status: Prescription
Patent and Exclusivity Information
100MG
Marketing Status: Prescription
Active Ingredient: CYCLOSPORINE
Proprietary Name: SANDIMMUNE
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 100MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AB2
Application Number: N050625
Product Number: 002
Approval Date: Mar 2, 1990
Applicant Holder Full Name: NOVARTIS PHARMACEUTICALS CORP
Marketing Status: Prescription
Patent and Exclusivity Information
Proprietary Name: SANDIMMUNE
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 100MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AB2
Application Number: N050625
Product Number: 002
Approval Date: Mar 2, 1990
Applicant Holder Full Name: NOVARTIS PHARMACEUTICALS CORP
Marketing Status: Prescription
Patent and Exclusivity Information